Newsroom

Public employees plan takes Sovaldi cost to court

The Southeastern Pennsylvania Transit Authority, or Septa, has a workforce of around 9,000, with many more covered in a health plan for retirees, and says it has spent $2.4 million on Sovaldi through the first 11 months of the year.

Read more

A new lawsuit claims $84,000 is way too much for this lifesaving drug

The federal lawsuit from Philadelphia’s public transit agency appears to be the first directly challenging the price of Sovaldi, which costs $84,000 overall during a normal 12-week course of treatment in the United States.

Read more

How this medication became 50 times more expensive overnight in the US

Lately, there has been a lot of of interest over a new drug to cure Hepatitis C—a disease that’s surpassed AIDS in number of death since 2007. Sovaldi, a medication produced by American pharmaceutical company Gilead, has a 90% success rate in treating the disease compared to a 50% success rate of the other existing treatments.

Read more

Consumers Will Pay More Out Of Pocket Next Year For Specialty Drugs

People with health coverage – including those who buy it through government insurance exchanges and Medicare beneficiaries – are likely to pay more out-of-pocket next year for so-called “specialty drugs,” which treat complex conditions, according to two studies from consulting firm Avalere Health.

Read more